At Bradford Hill, we have been leading clinical cancer research in Chile for more than 15 years, with a strong focus on immunotherapy. We actively contribute to the global search for new therapies and a definitive cure for this disease, which is today the leading cause of death in the country. We have centers in Santiago and Antofagasta, both with first-class infrastructure and advanced technology, where we run clinical trials following the highest international standards, always prioritizing the safety and well-being of our patients.